These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25643052)

  • 21. Emergence of drug-resistant influenza virus: population dynamical considerations.
    Regoes RR; Bonhoeffer S
    Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence and transmission of amantadine-resistant influenza A in a nursing home.
    Schilling M; Gravenstein S; Drinka P; Cox N; Krause P; Povinelli L; Shult P
    J Am Geriatr Soc; 2004 Dec; 52(12):2069-73. PubMed ID: 15571544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral agents for influenza, hepatitis C and herpesvirus, enterovirus and rhinovirus infections.
    Rawlinson WD
    Med J Aust; 2001 Jul; 175(2):112-6. PubMed ID: 11556411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?
    Bruno R; Fagiuoli S; Sacchi P
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):699-701. PubMed ID: 21905777
    [No Abstract]   [Full Text] [Related]  

  • 25. Importance of HCV genotype 1 subtypes for drug resistance and response to therapy.
    Wyles DL; Gutierrez JA
    J Viral Hepat; 2014 Apr; 21(4):229-40. PubMed ID: 24597691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enteroviruses: epidemic potential, challenges and opportunities with vaccines.
    Jartti M; Flodström-Tullberg M; Hankaniemi MM
    J Biomed Sci; 2024 Jul; 31(1):73. PubMed ID: 39010093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
    Deming P; McNicholl IR
    Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of insulin resistance in HIV/hepatitis C virus-coinfected patients.
    Eslam M; López-Cortés LF; Romero-Gomez M
    Curr Opin HIV AIDS; 2011 Nov; 6(6):553-8. PubMed ID: 21934619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enterovirus surveillance--United States, 1970-2005.
    Khetsuriani N; Lamonte-Fowlkes A; Oberst S; Pallansch MA;
    MMWR Surveill Summ; 2006 Sep; 55(8):1-20. PubMed ID: 16971890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV/hepatitis C virus coinfection management: changing guidelines and changing paradigms.
    Cooper CL; Klein MB
    HIV Med; 2014 Nov; 15(10):621-4. PubMed ID: 24802099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards the design of combination therapy for the treatment of enterovirus infections.
    Thibaut HJ; Leyssen P; Puerstinger G; Muigg A; Neyts J; De Palma AM
    Antiviral Res; 2011 Jun; 90(3):213-7. PubMed ID: 21466823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of enterovirus in Cameroon by partial 5'UTR-VP4 gene sequencing reveals a high genetic diversity and frequency of infections.
    Ayukekbong JA; Fobisong C; Lindh M; Nkuo-Akenji T; Bergström T; Norder H
    J Med Virol; 2014 Dec; 86(12):2092-101. PubMed ID: 24634190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perspective on emergence and re-emergence of amantadine resistant influenza A viruses in domestic animals in China.
    Wan XF; Carrel M; Long LP; Alker AP; Emch M
    Infect Genet Evol; 2013 Dec; 20():298-303. PubMed ID: 24060734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of antiviral agents for enteroviruses.
    Chen TC; Weng KF; Chang SC; Lin JY; Huang PN; Shih SR
    J Antimicrob Chemother; 2008 Dec; 62(6):1169-73. PubMed ID: 18931391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pleconaril revisited: clinical course of chronic enteroviral meningoencephalitis after treatment correlates with in vitro susceptibility.
    Wildenbeest JG; van den Broek PJ; Benschop KS; Koen G; Wierenga PC; Vossen AC; Kuijpers TW; Wolthers KC
    Antivir Ther; 2012; 17(3):459-66. PubMed ID: 22293148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enterovirus infections with special reference to enterovirus 71.
    Hsiung GD; Wang JR
    J Microbiol Immunol Infect; 2000 Mar; 33(1):1-8. PubMed ID: 10806956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influenza virus of seasonal influenza , high increase of resistance to amantadine and rimantadine].
    Nau JY
    Rev Med Suisse; 2006 Jan; 2(50):308. PubMed ID: 16503051
    [No Abstract]   [Full Text] [Related]  

  • 38. The frequency and biodiversity of poliovirus and non-polio enterovirus strains isolated from healthy children living in a limited area in Romania.
    Baicus A; Persu A; Dinu S; Joffret ML; Delpeyroux F; Oprisan G
    Arch Virol; 2011 Apr; 156(4):701-6. PubMed ID: 21221676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antivirals and influenza: frequency of resistance.
    Monto AS
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enteroviral infections in the pathogenesis of type 1 diabetes: new insights for therapeutic intervention.
    Richardson SJ; Morgan NG
    Curr Opin Pharmacol; 2018 Dec; 43():11-19. PubMed ID: 30064099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.